Beverly Davidson, PhD, a Batten disease researcher whose main focus is on the late infantile form of Batten disease (LINCL), and her team at the University of Iowa have discovered a way to cross the blood brain barrier and deliver therapeutic molecules directly into the brain. This is work that is historic for all of medical science - work that will touch the lives of countless people suffering from the NCLs (commonly known as Batten disease), all other lysosomal storage diseases and possibly other neurological diseases.

Dr. Davidson's project is very similar to the one being done by Sandra Hofmann, MD, PhD, whose work has been financially supported by Taylor's Tale for the past three years. Dr. Hofmann's research focuses on infantile NCL (INCL), and she is currently conducting preclinical studies. The continued support of our donors will help ensure that Dr. Hofmann's work will continue to progress with the potential to result in a cure for children with INCL.  

Learn More